Marketing-authorisation holder · United States
Coherus BioSciences, Inc.
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| LOQTORZI240mg/6ml(40mg/ml) · Injectable | Toripalimab | United States | Marketed | 2023 |
| UDENYCA6mg/0.6ml · Injectable | Pegfilgrastim | United States | Marketed | 2018 |
| YUSIMRY40mg · Injectable | Adalimumab | United States | Marketed | 2021 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 3 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.